Association between risk factors for vascular dementia and Adiponectin

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Song, Juhyun ^a   Lee, Won Taek ^a   Park, Kyung Ah ^a   Lee, Jong Eun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INSULIN; VASODILATOR AGENT; BIOLOGICAL MARKER;

ADIPOSE TISSUE; AGING; ATHEROSCLEROSIS; BRAIN; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; MODULATION; MULTIINFARCT DEMENTIA; NONHUMAN; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; BLOOD; COMORBIDITY; DEMENTIA, VASCULAR; DIABETES COMPLICATIONS; MORTALITY; PREVALENCE; RISK ASSESSMENT; STROKE; SURVIVAL RATE;

ADIPONECTIN; BIOLOGICAL MARKERS; COMORBIDITY; DEMENTIA, VASCULAR; DIABETES COMPLICATIONS; HUMANS; PREVALENCE; RISK ASSESSMENT; STROKE; SURVIVAL RATE;

EID: 84899999354     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/261672     Document Type: Review

References (213)

1. Ruitenberg A., Ott A., van Swieten J. C., Hofman A., Breteler M. M. B., Incidence of dementia: does gender make a difference? Neurobiology of Aging 2001 22 4 575 580 2-s2.0-0034968974 10.1016/S0197-4580(01)00231-7
2. Gorelick P. B., Scuteri A., Black S. E., Decarli C., Greenberg S. M., Iadecola C., Launer L. J., Laurent S., Lopez O. L., Nyenhuis D., Petersen R. C., Schneider J. A., Tzourio C., Arnett D. K., Bennett D. A., Chui H. C., Higashida R. T., Lindquist R., Nilsson P. M., Roman G. C., Sellke F. W., Seshadri S., Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011 42 9 2672 2713 2-s2.0-80052400687 10.1161/STR. 0b013e3182299496
3. Wortmann M., Dementia: a global health priority-highlights from an ADI and World Health Organization report. Alzheimer's Research & Therapy 2012 4 5, article 40 10.1186/alzrt143
4. Alzheimer's Association, 2012 Alzheimer's disease facts and figures. Alzheimer's & Dementia 2012 8 2 131 168 2-s2.0-84858225391 10.1016/j.jalz.2012.02.001
5. Craft S., The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Archives of Neurology 2009 66 3 300 305 2-s2.0-62449142597 10.1001/archneurol.2009.27
6. Fillit H., Nash D. T., Rundek T., Zuckerman A., Cardiovascular risk factors and dementia. The American Journal of Geriatric Pharmacotherapy 2008 6 2 100 118 2-s2.0-48149111799 10.1016/j.amjopharm.2008.06.004
7. Honjo K., Black S. E., Verhoeff N. P., Alzheimer's disease, cerebrovascular disease, and the β -amyloid cascade. The Canadian Journal of Neurological Sciences 2012 39 6 712 728
8. Purnell C., Gao S., Callahan C. M., Hendrie H. C., Cardiovascular risk factors and incident alzheimer disease: a systematic review of the literature. Alzheimer Disease and Associated Disorders 2009 23 1 1 10 2-s2.0-62949174568 10.1097/WAD.0b013e318187541c
9. Schneider J. A., Arvanitakis Z., Bang W., Bennett D. A., Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007 69 24 2197 2204 2-s2.0-35748959415 10.1212/01.wnl.0000271090. 28148.24
10. Toledo J. B., Arnold S. E., Raible K., Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. Brain 2013 136 9 2697 2706 10.1093/brain/awt188
11. Roman G. C., Tatemichi T. K., Erkinjuntti T., Cummings J. L., Masdeu J. C., Garcia J. H., Amaducci L., Orgogozo J.-M., Brun A., Hofman A., Moody D. M., O'Brien M. D., Yamaguchi T., Grafman J., Drayer B. P., Bennett D. A., Fisher M., Ogata J., Kokmen E., Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993 43 2 250 260 2-s2.0-0027534657
12. Hachinski V. C., Bowler J. V., Loeb C., Roman G. C., Tatemichi T. K., Vascular dementia. Neurology 1993 43 10 2159 2161 2-s2.0-0027682504
13. UK Prospective Diabetes Study (UKPDS) Group, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet 1998 352 9131 837 853 2-s2.0-0032511583 10.1016/S0140-6736(98)07019-6
14. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K., Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. The Journal of Clinical Investigation 2006 116 7 1784 1792 2-s2.0-33745834319 10.1172/JCI29126
15. Shimabukuro M., Higa N., Asahi T., Oshiro Y., Takasu N., Tagawa T., Ueda S., Shimomura I., Funahashi T., Matsuzawa Y., Hypoadiponectinemia is closely linked to endothelial dysfunction in man. The Journal of Clinical Endocrinology & Metabolism 2003 88 7 3236 3240 2-s2.0-0038637251 10.1210/jc.2002-021883
16. Chen M. P., Tsai J. C., Chung F. M., Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 4 821 826 10.1161/01.ATV.0000157784.25920.a7
17. Snijder M. B., Heine R. J., Seidell J. C., Bouter L. M., Stehouwer C. D. A., Nijpels G., Funahashi T., Matsuzawa Y., Shimomura I., Dekker J. M., Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women the hoorn study. Diabetes Care 2006 29 11 2498 2503 2-s2.0-33845499740 10.2337/dc06-0952
18. Jansson P.-A., Pellmé F., Hammarstedt A., Sandqvist M., Brekke H., Caidahl K., Forsberg M., Volkmann R., Carvalho E., Funahashi T., Matsuzawa Y., Wiklund O., Yang X., Taskinen M.-R., Smith U., A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin. The FASEB Journal 2003 17 11 1434 1440 2-s2.0-0042209622 10.1096/fj.02-1132com
19. Dunajska K., Milewicz A., Jdrzejuk D., Szymczak J., Kuliczkowski W., Salomon P., Biały D., Pocztek K., Nowicki P., Plasma adiponectin concentration in relation to severity of coronary atherosclerosis and cardiovascular risk factors in middle-aged men. Endocrine 2004 25 3 215 221 2-s2.0-22244473951 10.1385/ENDO:25:3:215
20. Shoji T., Koyama H., Fukumoto S., Maeno T., Yokoyama H., Shinohara K., Emoto M., Shoji T., Yamane T., Hino M., Shioi A., Nishizawa Y., Platelet activation is associated with hypoadiponectinemia and carotid atherosclerosis. Atherosclerosis 2006 188 1 190 195 2-s2.0-33746486942 10.1016/j.atherosclerosis. 2005.10.034
21. Saltevo J., Laakso M., Jokelainen J., Keinänen-Kiukaanniemi S., Kumpusalo E., Vanhala M., Levels of adiponectin, C-reactive protein and interleukin-1 receptor antagonist are associated with insulin sensitivity: a population-based study. Diabetes/Metabolism Research and Reviews 2008 24 5 378 383 2-s2.0-49449095163 10.1002/dmrr.831
22. Wannamethee S. G., Lowe G. D. O., Rumley A., Cherry L., Whincup P. H., Sattar N., Adipokines and risk of type 2 diabetes in older men. Diabetes Care 2007 30 5 1200 1205 2-s2.0-34247636175 10.2337/dc06-2416
23. Heidemann C., Sun Q., van Dam R. M., Meigs J. B., Zhang C., Tworoger S. S., Mantzoros C. S., Hu F. B., Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Annals of Internal Medicine 2008 149 5 307 316 2-s2.0-51049123168
24. Ley S. H., Harris S. B., Connelly P. W., Mamakeesick M., Gittelsohn J., Hegele R. A., Retnakaran R., Zinman B., Hanley A. J. G., Adipokines and incident type 2 diabetes in a Canadian Aborigine population: the Sandy Lake Health and Diabetes Project. Diabetes Care 2008 31 7 1410 1415
25. Tabák A. G., Brunner E. J., Miller M. A., Karanam S., McTernan P. G., Cappuccio F. P., Witte D. R., Low serum adiponectin predicts 10-year risk of type 2 diabetes and hba1c independently of obesity, lipids, and inflammation: Whitehall II study. Hormone and Metabolic Research 2009 41 8 626 629 2-s2.0-70349580117 10.1055/s-0029-1216359
26. Koenig W., Khuseyinova N., Baumert J., Meisinger C., Löwel H., Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. Journal of the American College of Cardiology 2006 48 7 1369 1377 2-s2.0-33748933358 10.1016/j.jacc.2006.06.053
27. Thal D. R., Grinberg L. T., Attems J., Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain. Experimental Gerontology 2012 47 11 816 824 10.1016/j.exger.2012.05.023
28. Cohen R. A., Tong X., Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease. Journal of Cardiovascular Pharmacology 2010 55 4 308 316 2-s2.0-77951736264 10.1097/FJC.0b013e3181d89670
29. Iadecola C., Davisson R. L., Hypertension and cerebrovascular dysfunction. Cell Metabolism 2008 7 6 476 484 2-s2.0-44349096287 10.1016/j.cmet.2008.03.010
30. Yates K. F., Sweat V., Yau P. L., Turchiano M. M., Convit A., Impact of metabolic syndrome on cognition and brain: a selected review of the literature. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 9 2060 2067 10.1161/ATVBAHA.112.252759
31. Faraci F. M., Protecting against vascular disease in brain. American Journal of Physiology: Heart and Circulatory Physiology 2011 300 5 H1566 H1582 2-s2.0-79955770689 10.1152/ajpheart.01310.2010
32. Sahathevan R., Brodtmann A., Donnan G. A., Dementia, stroke, and vascular risk factors; a review. International Journal of Stroke 2012 7 1 61 73 2-s2.0-84155184459 10.1111/j.1747-4949.2011.00731.x
33. Corrada M. M., Brookmeyer R., Berlau D., Paganini-Hill A., Kawas C. H., Prevalence of dementia after age 90: results from the 90+ study. Neurology 2008 71 5 337 343 2-s2.0-67649300521 10.1212/01.wnl.0000310773.65918.cd
34. Claassen J. A. H. R., Diaz-Arrastia R., Martin-Cook K., Levine B. D., Zhang R., Altered cerebral hemodynamics in early alzheimer disease: a pilot study using transcranial doppler. Journal of Alzheimer's Disease 2009 17 3 621 629 2-s2.0-67849092811 10.3233/JAD-2009-1079
35. Gao Y. Z., Zhang J. J., Liu H., Wu G. Y., Xiong L., Shu M., Regional cerebral blood flow and cerebrovascular reactivity in Alzheimer's disease and vascular dementia assessed by arterial spinlabeling magnetic resonance imaging. Current Neurovascular Research 2013 10 1 49 53 10.2174/156720213804806016
36. Luckhaus C., Flüß M. O., Wittsack H.-J., Grass-Kapanke B., Jänner M., Khalili-Amiri R., Friedrich W., Supprian T., Gaebel W., Mödder U., Cohnen M., Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging. NeuroImage 2008 40 2 495 503 2-s2.0-40649126330 10.1016/j.neuroimage.2007.11.053
37. Mentis M. J., Horwitz B., Grady C. L., Alexander G. E., VanMeter J. W., Maisog J. M., Pietrini P., Schapiro M. B., Rapoport S. I., Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET. American Journal of Psychiatry 1996 153 1 32 40 2-s2.0-0030057716
38. Niedermeyer E., Alzheimer disease: caused by primary deficiency of the cerebral blood flow. Clinical EEG and Neuroscience 2006 37 3 175 177 2-s2.0-33747127863
39. Ruitenberg A., den Heijer T., Bakker S. L. M., van Swieten J. C., Koudstaal P. J., Hofman A., Breteler M. M. B., Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam study. Annals of Neurology 2005 57 6 789 794 2-s2.0-20444383813 10.1002/ana.20493
40. Sabayan B., Jansen S., Oleksik A. M., van Osch M. J. P., van Buchem M. A., van Vliet P., de Craen A. J. M., Westendorp R. G. J., Cerebrovascular hemodynamics in Alzheimer's disease and vascular dementia: a meta-analysis of transcranial Doppler studies. Ageing Research Reviews 2012 11 2 271 277 2-s2.0-84855901613 10.1016/j.arr.2011.12.009
41. Tanaka M., Fukuyama H., Yamauchi H., Narita M., Nabatame H., Yokode M., Fujimoto N., Kita T., Murakami M., Regional cerebral blood flow abnormalities in nondemented patients with memory impairment. Journal of Neuroimaging 2002 12 2 112 118 2-s2.0-0036196090
42. Iadecola C., Neurovascular regulation in the normal brain and in Alzheimer's disease. Nature Reviews Neuroscience 2004 5 5 347 360 2-s2.0-2342614850
43. Achike F. I., To N.-H. P., Wang H., Kwan C.-Y., Obesity, metabolic syndrome, adipocytes and vascular function: a holistic viewpoint. Clinical and Experimental Pharmacology and Physiology 2011 38 1 1 10 2-s2.0-78650670158 10.1111/j.1440-1681.2010.05460.x
44. Okamoto Y., Kihara S., Funahashi T., Matsuzawa Y., Libby P., Adiponectin: a key adipocytokine in metabolic syndrome. Clinical Science 2006 110 3 267 278 2-s2.0-33644770179 10.1042/CS20050182
45. Scherer P. E., Williams S., Fogliano M., Baldini G., Lodish H. F., A novel serum protein similar to C1q, produced exclusively in adipocytes. The Journal of Biological Chemistry 1995 270 45 26746 26749 2-s2.0-0028787490 10.1074/jbc.270.45.26746
46. Shapiro L., Scherer P. E., The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Current Biology 1998 8 6 335 338 2-s2.0-0032510463
47. Ruan H., Lodish H. F., Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor- α Cytokine and Growth Factor Reviews 2003 14 5 447 455 2-s2.0-0041374029 10.1016/S1359-6101(03)00052-2
48. Kissebah A. H., Sonnenberg G. E., Myklebust J., Goldstein M., Broman K., James R. G., Marks J. A., Krakower G. R., Jacob H. J., Weber J., Martin L., Blangero J., Comuzzie A. G., Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proceedings of the National Academy of Sciences of the United States of America 2000 97 26 14478 14483 2-s2.0-14344273991 10.1073/pnas.97.26.14478
49. Mori Y., Otabe S., Dina C., Yasuda K., Populaire C., Lecoeur C., Vatin V., Durand E., Hara K., Okada T., Tobe K., Boutin P., Kadowaki T., Froguel P., Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate loci on 7p and 11p. Diabetes 2002 51 4 1247 1255 2-s2.0-0036230486
50. Vasseur F., Helbecque N., Dina C., Lobbens S., Delannoy V., Gaget S., Boutin P., Vaxillaire M., Leprêtre F., Dupont S., Hara K., Clément K., Bihain B., Kadowaki T., Froguel P., Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Human Molecular Genetics 2002 11 21 2607 2614 2-s2.0-18644369745
51. Leu H.-B., Chung C.-M., Lin S.-J., Jong Y.-S., Pan W.-H., Chen J.-W., Adiponectin gene polymorphism is selectively associated with the concomitant presence of metabolic syndrome and essential hypertension. PLoS ONE 2011 6 5 2-s2.0-79957625762 10.1371/journal.pone.0019999 e19999
52. Stumvoll M., Tschritter O., Fritsche A., Staiger H., Renn W., Weisser M., Machicao F., Häring H., Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 2002 51 1 37 41 2-s2.0-0036091918
53. Kollias A., Tsiotra P. C., Ikonomidis I., Maratou E., Mitrou P., Kyriazi E., Boutati E., Lekakis J., Economopoulos T., Kremastinos D. T., Dimitriadis G., Raptis S. A., Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease. Cardiovascular Diabetology 2011 10, article 14 2-s2.0-79351469894 10.1186/1475-2840-10-14
54. Hara K., Boutin P., Mori Y., Tobe K., Dina C., Yasuda K., Yamauchi T., Otabe S., Okada T., Eto K., Kadowaki H., Hagura R., Akanuma Y., Yazaki Y., Nagai R., Taniyama M., Matsubara K., Yoda M., Nakano Y., Kimura S., Tomita M., Kimura S., Ito C., Froguel P., Kadowaki T., Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002 51 2 536 540
55. Bermudez V. J., Rojas E., Toledo A., Single-nucleotide polymorphisms in adiponectin, AdipoR1, and AdipoR2 genes: insulin resistance and type 2 diabetes mellitus candidate genes. American Journal of Therapeutics 2013 20 4 414 421 10.1097/MJT.0b013e318235f206
56. Menzaghi C., Ercolino T., Paola R. D., Berg A. H., Warram J. H., Scherer P. E., Trischitta V., Doria A., A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002 51 7 2306 2312 2-s2.0-0036307162
57. Zhang Z., Tian H., Zhao Y., Meta-analysis of the association between adiponectin gene +276 g/T polymorphisms and coronary atherosclerotic heart disease. Wei Sheng Yan Jiu 2013 42 4 693 697
58. Yamauchi T., Kamon J., Waki H., Imai Y., Shimozawa N., Hioki K., Uchida S., Ito Y., Takakuwa K., Matsui J., Takata M., Eto K., Terauchi Y., Komeda K., Tsunoda M., Murakami K., Ohnishi Y., Naitoh T., Yamamura K., Ueyama Y., Froguel P., Kimura S., Nagai R., Kadowaki T., Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. The Journal of Biological Chemistry 2003 278 4 2461 2468 2-s2.0-0037462684 10.1074/jbc. M209033200
59. Ziemke F., Mantzoros C. S., Adiponectin in insulin resistance: lessons from translational research. The American Journal of Clinical Nutrition 2010 91 1 258S 261S 2-s2.0-74049157079 10.3945/ajcn.2009.28449C
60. Spranger J., Verma S., Göhring I., Bobbert T., Seifert J., Sindler A. L., Pfeiffer A., Hileman S. M., Tschöp M., Banks W. A., Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 2006 55 1 141 147 2-s2.0-33644748270 10.2337/diabetes.55.1.141
61. Kubota N., Yano W., Kubota T., Yamauchi T., Itoh S., Kumagai H., Kozono H., Takamoto I., Okamoto S., Shiuchi T., Suzuki R., Satoh H., Tsuchida A., Moroi M., Sugi K., Noda T., Ebinuma H., Ueta Y., Kondo T., Araki E., Ezaki O., Nagai R., Tobe K., Terauchi Y., Ueki K., Minokoshi Y., Kadowaki T., Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metabolism 2007 6 1 55 68 2-s2.0-34347255023 10.1016/j.cmet.2007. 06.003
62. Psilopanagioti A., Papadaki H., Kranioti E. F., Alexandrides T. K., Varakis J. N., Expression of adiponectin and adiponectin receptors in human pituitary gland and brain. Neuroendocrinology 2009 89 1 38 47 2-s2.0-59049105151 10.1159/000151396
63. Zoico E., di Francesco V., Mazzali G., Vettor R., Fantin F., Bissoli L., Guariento S., Bosello O., Zamboni M., Adipocytokines, fat distribution, and insulin resistance in elderly men and women. The Journals of Gerontology A: Biological Sciences and Medical Sciences 2004 59 9 935 939 2-s2.0-5644289328
64. Cnop M., Havel P. J., Utzschneider K. M., Carr D. B., Sinha M. K., Boyko E. J., Retzlaff B. M., Knopp R. H., Brunzell J. D., Kahn S. E., Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003 46 4 459 469 2-s2.0-0038293399
65. Kanaya A. M., Harris T., Goodpaster B. H., Tylavsky F., Cummings S. R., Adipocytokines attenuate the association between visceral adiposity and diabetes in older adults. Diabetes Care 2004 27 6 1375 1380 2-s2.0-2542471005 10.2337/diacare.27.6.1375
66. Ahmadizad S., Haghighi A. H., Hamedinia M. R., Effects of resistance versus endurance training on serum adiponectin and insulin resistance index. European Journal of Endocrinology 2007 157 5 625 631 2-s2.0-36549041433 10.1530/EJE-07-0223
67. Blüher M., Williams C. J., Klöting N., Hsi A., Ruschke K., Oberbach A., Fasshauer M., Berndt J., Schön M. R., Wolk A., Stumvoll M., Mantzoros C. S., Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training. Diabetes Care 2007 30 12 3110 3115 2-s2.0-37149051275 10.2337/dc07-1257
68. Blüher M., Bullen J. W. Jr., Lee J. H., Kralisch S., Fasshauer M., Klöting N., Niebauer J., Schön M. R., Williams C. J., Mantzoros C. S., Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. The Journal of Clinical Endocrinology & Metabolism 2006 91 6 2310 2316 2-s2.0-33744949934 10.1210/jc.2005-2556
69. Tilg H., Moschen A. R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology 2006 6 10 772 783 2-s2.0-33748992313 10.1038/nri1937
70. Ridker P. M., Buring J. E., Cook N. R., Rifai N., C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003 107 3 391 397 2-s2.0-0037469255
71. Pajvani U. B., Scherer P. E., Adiponectin: systemic contributor to insulin sensitivity. Current Diabetes Reports 2003 3 3 207 213 2-s2.0-0041519355
72. Lim S., Sung H. C., Jeong I.-K., Jae H. K., Min K. M., Kyong S. P., Hong K. L., Kim Y.-B., Hak C. J., Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle-aged women. The Journal of Clinical Endocrinology & Metabolism 2008 93 6 2263 2268 2-s2.0-45149097354 10.1210/jc.2007-2028
73. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B. B., Kadowaki T., Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 2002 8 11 1288 1295 2-s2.0-0036851817 10.1038/nm788
74. Stefan N., Vozarova B., Funahashi T., Matsuzawa Y., Weyer C., Lindsay R. S., Youngren J. F., Havel P. J., Pratley R. E., Bogardus C., Antonio Tataranni P., Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002 51 6 1884 1888 2-s2.0-0036266897
75. Lihn A. S., Pedersen S. B., Richelsen B., Adiponectin: action, regulation and association to insulin sensitivity. Obesity Reviews 2005 6 1 13 21 2-s2.0-12444304182 10.1111/j.1467-789X.2005.00159.x
76. Iglseder B., Mackevics V., Stadlmayer A., Tasch G., Ladurner G., Paulweber B., Plasma adiponectin levels and sonographic phenotypes of subclinical carotid artery atherosclerosis: data from the SAPHIR study. Stroke 2005 36 12 2577 2582 2-s2.0-33644698960 10.1161/01.STR.0000190834.00284.fd
77. Wang W.-Q., Zhang H.-F., Gao G.-X., Bai Q.-X., Li R., Wang X.-M., Adiponectin inhibits hyperlipidemia-induced platelet aggregation via attenuating oxidative/nitrative stress. Physiological Research 2011 60 2 347 354 2-s2.0-79959265421
78. Restituto P., Colina I., Varo J. J., Varo N., Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome. American Journal of Physiology: Endocrinology and Metabolism 2010 298 5 E1072 E1077 2-s2.0-77950817472 10.1152/ajpendo.00728.2009
79. Prince M., Bryce R., Albanese E., Wimo A., Ribeiro W., Ferri C. P., The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer's & Dementia 2013 9 1 63.e2 75.e2 10.1016/j.jalz.2012.11.007
80. Brewer G. J., Epigenetic oxidative redox shift (EORS) theory of aging unifies the free radical and insulin signaling theories. Experimental Gerontology 2010 45 3 173 179 2-s2.0-76749126321 10.1016/j.exger.2009.11.007
81. Duarte A. I., Moreira P. I., Oliveira C. R., Insulin in central nervous system: more than just a peripheral hormone. Journal of Aging Research 2012 2012 21 384017 10.1155/2012/384017
82. Kappeler L., Filho C. D. M., Dupont J., Leneuve P., Cervera P., Périn L., Loudes C., Blaise A., Klein R., Epelbaum J., le Bouc Y., Holzenberger M., Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism. PLoS Biology 2008 6 10 e254 2-s2.0-58149229964 10.1371/journal.pbio.0060254
83. Franceschi C., Olivieri F., Marchegiani F., Cardelli M., Cavallone L., Capri M., Salvioli S., Valensin S., de Benedictis G., di Iorio A., Caruso C., Paolisso G., Monti D., Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mechanisms of Ageing and Development 2005 126 2 351 361 2-s2.0-19944392873 10.1016/j.mad.2004.08.028
84. Lorenzini A., Salmon A. B., Lerner C., Mice producing reduced levels of insulin-like growth factor type 1 display an increase in maximum, but not mean, life span. The Journals of Gerontology A: Biological Sciences and Medical Sciences 2014 69 4 410 419 10.1093/gerona/glt108
85. Selman C., Lingard S., Choudhury A. I., Batterham R. L., Claret M., Clements M., Ramadani F., Okkenhaug K., Schuster E., Blanc E., Piper M. D., Al-Qassab H., Speakman J. R., Carmignac D., Robinson I. C. A., Thornton J. M., Gems D., Partridge L., Withers D. J., Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. The FASEB Journal 2008 22 3 807 818 2-s2.0-40449142493 10.1096/fj.07-9261com
86. Blüher M., Kahn B. B., Kahn C. R., Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003 299 5606 572 574 2-s2.0-0037942739 10.1126/science.1078223
87. Holzenberger M., Dupont J., Ducos B., Leneuve P., Géloën A., Even P. C., Cervera P., le Bouc Y., IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003 421 6919 182 187 2-s2.0-0347664057 10.1038/nature01298
88. Besson A., Salemi S., Gallati S., Jenal A., Horn R., Mullis P. S., Mullis P. E., Reduced longevity in untreated patients with isolated growth hormone deficiency. The Journal of Clinical Endocrinology & Metabolism 2003 88 8 3664 3667 2-s2.0-0041382468 10.1210/jc.2002-021938
89. Ford E. S., Giles W. H., Dietz W. H., Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. The Journal of the American Medical Association 2002 287 3 356 359 2-s2.0-0037116641
90. Kobayashi J., Nishimura K., Matoba M., Maekawa N., Mabuchi H., Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome according to the Japanese criteria. Circulation Journal 2007 71 11 1734 1737 2-s2.0-36949039445 10.1253/circj.71.1734
91. Fulop T., Larbi A., Douziech N., Insulin receptor and ageing. Pathologie Biologie 2003 51 10 574 580 2-s2.0-0344413421 10.1016/j.patbio.2003.09.007
92. Muller A. P., Fernandez A. M., Haas C., Zimmer E., Portela L. V., Torres-Aleman I., Reduced brain insulin-like growth factor I function during aging. Molecular and Cellular Neuroscience 2012 49 1 9 12 2-s2.0-84155163218 10.1016/j.mcn.2011.07.008
93. Kim J.-A., Wei Y., Sowers J. R., Role of mitochondrial dysfunction in insulin resistance. Circulation Research 2008 102 4 401 414 2-s2.0-41949114990 10.1161/CIRCRESAHA.107.165472
94. Abdul-Ghani M. A., DeFronzo R. A., Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus. Current Diabetes Reports 2008 8 3 173 178 2-s2.0-52649149879 10.1007/s11892-008-0030-1
95. Petersen K. F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D. L., DiPietro L., Cline G. W., Shulman G. I., Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003 300 5622 1140 1142 2-s2.0-0038025371 10.1126/science.1082889
96. Barazzoni R., Short K. R., Nair K. S., Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart. The Journal of Biological Chemistry 2000 275 5 3343 3347 2-s2.0-0034602958 10.1074/jbc.275.5.3343
97. Cortopassi G. A., Shibata D., Soong N.-W., Arnheim N., A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proceedings of the National Academy of Sciences of the United States of America 1992 89 16 7370 7374 2-s2.0-0026732706
98. Benbassat C. A., Maki K. C., Unterman T. G., Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures. The Journal of Clinical Endocrinology & Metabolism 1997 82 5 1484 1491 2-s2.0-0031006203
99. Corpas E., Harman S. M., Blackman M. R., Human growth hormone and human aging. Endocrine Reviews 1993 14 1 20 39 2-s2.0-0027510448 10.1210/er.14.1.20
100. Rudman D., Feller A. G., Nagraj H. S., Gergans G. A., Lalitha P. Y., Goldberg A. F., Schlenker R. A., Cohn L., Rudman I. W., Mattson D. E., Effects of human growth hormone in men over 60 years old. The New England Journal of Medicine 1990 323 1 1 6 2-s2.0-0025368959
101. Gulcelik N. E., Halil M., Ariogul S., Usman A., Adipocytokines and aging: adiponectin and leptin. Minerva Endocrinologica 2013 38 2 203 210
102. Minamino T., Orimo M., Shimizu I., Kunieda T., Yokoyama M., Ito T., Nojima A., Nabetani A., Oike Y., Matsubara H., Ishikawa F., Komuro I., A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nature Medicine 2009 15 9 1082 1087 2-s2.0-69949150673 10.1038/nm.2014
103. Schulingkamp R. J., Pagano T. C., Hung D., Raffa R. B., Insulin receptors and insulin action in the brain: review and clinical implications. Neuroscience and Biobehavioral Reviews 2000 24 8 855 872 2-s2.0-0033664539 10.1016/S0149-7634(00)00040-3
104. van der Heide L. P., Ramakers G. M. J., Smidt M. P., Insulin signaling in the central nervous system: learning to survive. Progress in Neurobiology 2006 79 4 205 221 2-s2.0-33748295795 10.1016/j.pneurobio.2006.06.003
105. Cole A. R., Astell A., Green C., Sutherland C., Molecular connexions between dementia and diabetes. Neuroscience and Biobehavioral Reviews 2007 31 7 1046 1063 2-s2.0-34548241662 10.1016/j.neubiorev.2007.04.004
106. Plum L., Schubert M., Brüning J. C., The role of insulin receptor signaling in the brain. Trends in Endocrinology and Metabolism 2005 16 2 59 65 2-s2.0-13944272576
107. Gasparini L., Netzer W. J., Greengard P., Xu H., Does insulin dysfunction play a role in Alzheimer's disease? Trends in Pharmacological Sciences 2002 23 6 288 293 2-s2.0-0036591657 10.1016/S0165-6147(02)02037-0
108. Bosco D., Fava A., Plastino M., Montalcini T., Pujia A., Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis. Journal of Cellular and Molecular Medicine 2011 15 9 1807 1821 2-s2.0-79960555700 10.1111/j.1582-4934.2011.01318.x
109. Fang X., Yu S. X., Lu Y., Bast R. C. Jr., Woodgett J. R., Mills G. B., Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proceedings of the National Academy of Sciences of the United States of America 2000 97 22 11960 11965 2-s2.0-12944250922 10.1073/pnas.220413597
110. Kim B., Feldman E. L., Insulin resistance in the nervous system. Trends in Endocrinology and Metabolism 2012 23 3 133 141 2-s2.0-84857691558
111. Cunnane S., Nugent S., Roy M., Courchesne-Loyer A., Croteau E., Tremblay S., Castellano A., Pifferi F., Bocti C., Paquet N., Begdouri H., Bentourkia M., Turcotte E., Allard M., Barberger-Gateau P., Fulop T., Rapoport S. I., Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition 2011 27 1 3 20 2-s2.0-78649962844 10.1016/j.nut.2010.07.021
112. McNay E. C., Recknagel A. K., Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes. Neurobiology of Learning and Memory 2011 96 3 432 442 2-s2.0-80053624120 10.1016/j.nlm.2011.08.005
113. Wang Y. T., Salter M. W., Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature 1994 369 6477 233 235 2-s2.0-0028360327 10.1038/369233a0
114. van der Heide L. P., Kamal A., Artola A., Gispen W. H., Ramakers G. M. J., Insulin modulates hippocampal activity-dependent synaptic plasticity in a N -methyl-D-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner. Journal of Neurochemistry 2005 94 4 1158 1166 2-s2.0-23844470857 10.1111/j.1471-4159.2005.03269.x
115. Correia S. C., Santos R. X., Perry G., Zhu X., IMoreira P., Smith M. A., Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease? Ageing Research Reviews 2011 10 2 264 273 2-s2.0-79952449386 10.1016/j.arr.2011.01.001
116. Steen E., Terry B. M., Rivera E. J., Cannon J. L., Neely T. R., Tavares R., Xu X. J., Wands J. R., de la Monte S. M., Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? Journal of Alzheimer's Disease 2005 7 1 63 80 2-s2.0-15244351255
117. Rivera E. J., Goldin A., Fulmer N., Tavares R., Wands J. R., de la Monte S. M., Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. Journal of Alzheimer's Disease 2005 8 3 247 268 2-s2.0-33644591150
118. Craft S., Asthana S., Newcomer J. W., Wilkinson C. W., Matos I. T., Baker L. D., Cherrier M., Lofgreen C., Latendresse S., Petrova A., Plymate S., Raskind M., Grimwood K., Veith R. C., Enhancement of memory in Alzheimer disease
119. Vingtdeux V., Davies P., Dickson D. W., Marambaud P., AMPK is abnormally activated in tangle-and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies. Acta Neuropathologica 2011 121 3 337 349 2-s2.0-79952135316 10.1007/s00401-010-0759-x
120. Park C. R., Seeley R. J., Craft S., Woods S. C., Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiology and Behavior 2000 68 4 509 514 2-s2.0-0034012731 10.1016/S0031-9384(99)00220-6
121. Craft S., Asthana S., Schellenberg G., Cherrier M., Baker L. D., Newcomer J., Plymate S., Latendresse S., Petrova A., Raskind M., Peskind E., Lofgreen C., Grimwood K., Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender. Neuroendocrinology 1999 70 2 146 152 2-s2.0-0032841571 10.1159/000054469
122. Reger M. A., Watson G. S., Green P. S., Wilkinson C. W., Baker L. D., Cholerton B., Fishel M. A., Plymate S. R., Breitner J. C. S., DeGroodt W., Mehta P., Craft S., Intranasal insulin improves cognition and modulates β -amyloid in early AD. Neurology 2008 70 6 440 448 2-s2.0-40349091597 10.1212/01.WNL.0000265401.62434.36
123. Cornier M.-A., Dabelea D., Hernandez T. L., Lindstrom R. C., Steig A. J., Stob N. R., van Pelt R. E., Wang H., Eckel R. H., The metabolic syndrome. Endocrine Reviews 2008 29 7 777 822 2-s2.0-57349096045 10.1210/er.2008-0024
124. Vu V., Bui P., Eguchi M., Xu A., Sweeney G., Globular adiponectin induces LKB1/AMPK-dependent glucose uptake via actin cytoskeleton remodeling. Journal of Molecular Endocrinology 2013 51 1 155 165 10.1530/JME-13-0059
125. Song J., Lee J. E., Adiponectin as a new paradigm for approaching Alzheimer's disease. Anatomy & Cell Biology 2013 46 4 229 234 10.5115/acb.2013.46.4.229
126. Mao X., Kikani C. K., Riojas R. A., Langlais P., Wang L., Ramos F. J., Fang Q., Christ-Roberts C. Y., Hong J. Y., Kim R.-Y., Liu F., Dong L. Q., APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nature Cell Biology 2006 8 5 516 523 2-s2.0-33744972277
127. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O., Akanuma Y., Gavrilova O., Vinson C., Reitman M. L., Kagechika H., Shudo K., Yoda M., Nakano Y., Tobe K., Nagai R., Kimura S., Tomita M., Froguel P., Kadowaki T., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 2001 7 8 941 946 2-s2.0-17944365228 10.1038/90984
128. Leow M. K. S., Addy C. L., Mantzoros C. S., Clinical review 159: human immunodeficiency virus/highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies. The Journal of Clinical Endocrinology & Metabolism 2003 88 5 1961 1976 2-s2.0-0038030965 10.1210/jc.2002-021704
129. Kubota N., Terauchi Y., Yamauchi T., Kubota T., Moroi M., Matsui J., Eto K., Yamashita T., Kamon J., Satoh H., Yano W., Froguel P., Nagai R., Kimura S., Kadowaki T., Noda T., Disruption of adiponectin causes insulin resistance and neointimal formation. The Journal of Biological Chemistry 2002 277 29 25863 25866 2-s2.0-0037135523 10.1074/jbc.C200251200
130. Okamoto M., Ohara-Imaizumi M., Kubota N., Hashimoto S., Eto K., Kanno T., Kubota T., Wakui M., Nagai R., Noda M., Nagamatsu S., Kadowaki T., Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration. Diabetologia 2008 51 5 827 835 2-s2.0-41849100299 10.1007/s00125-008-0944-9
131. Yamaguchi N., Kukita T., Li Y.-J., Martinez Argueta J. G., Saito T., Hanazawa S., Yamashita Y., Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans. FEMS Immunology & Medical Microbiology 2007 49 1 28 34 2-s2.0-33846471601 10.1111/j.1574-695X.2006.00164.x
132. Hofman A., Ott A., Breteler M. M. B., Bots M. L., Slooter A. J. C., van Harskamp F., van Duijn C. N., van Broeckhoven C., Grobbee D. E., Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. The Lancet 1997 349 9046 151 154 2-s2.0-0031026879 10.1016/S0140-6736(96)09328-2
133. McAlister F. A., Zarnke K. B., Campbell N. R. C., Feldman R. D., Levine M., Mahon J., Grover S. A., Lewanczuk R., Leenen F., Tobe S., Lebel M., Stone J., Schiffrin E. L., Rabkin S. W., Ogilvie R. I., Larochelle P., Jones C., Honos G., Fodor G., Burgess E., Hamet P., Herman R., Irvine J., Culleton B., Wright J. M., The 2001 Canadian recommendations for the management of hypertension-part two: therapy. Canadian Journal of Cardiology 2002 18 6 625 641 2-s2.0-0036055085
134. Jandeleit-Dahm K., Cooper M. E., Hypertension and diabetes. Current Opinion in Nephrology and Hypertension 2002 11 2 221 228 2-s2.0-0036191911 10.1097/00041552-200203000-00014
135. Schrier R. W., Estacio R. O., Esler A., Mehler P., Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International 2002 61 3 1086 1097 2-s2.0-0036190137 10.1046/j.1523-1755.2002.00213.x
136. McNay E. C., The impact of recurrent hypoglycemia on cognitive function in aging. Neurobiology of Aging 2005 26 supplement 1 S76 S79 2-s2.0-28444437353 10.1016/j.neurobiolaging.2005.08.014
137. Weyer C., Hanson R. L., Tataranni P. A., Bogardus C., Pratley R. E., A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes 2000 49 12 2094 2101 2-s2.0-0033656672
138. Cox D. J., Kovatchev B. P., Gonder-Frederick L. A., Summers K. H., McCall A., Grimm K. J., Clarke W. L., Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care 2005 28 1 71 77 2-s2.0-11844306546 10.2337/diacare.28.1.71
139. Yaffe K., Blackwell T., Kanaya A. M., Davidowitz N., Barrett-Connor E., Krueger K., Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004 63 4 658 663 2-s2.0-4143119982
140. Imagawa A., Funahashi T., Nakamura T., Moriwaki M., Tanaka S., Nishizawa H., Sayama K., Uno S., Iwahashi H., Yamagata K., Miyagawa J.-I., Matsuzawa Y., Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 2002 25 9 1665 1666 2-s2.0-0036728279
141. Zhu M., Miura J., Lu L. X., Bernier M., DeCabo R., Lane M. A., Roth G. S., Ingram D. K., Circulating adiponectin levels increase in rats on caloric restriction: the potential for insulin sensitization. Experimental Gerontology 2004 39 7 1049 1059 2-s2.0-3242720519 10.1016/j.exger.2004.03.024
142. Stefan N., Bunt J. C., Salbe A. D., Funahashi T., Matsuzawa Y., Antonio Tataranni P., Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. The Journal of Clinical Endocrinology & Metabolism 2002 87 10 4652 4656 2-s2.0-0036775539 10.1210/jc.2002-020694
143. Krakoff J., Funahashi T., Stehouwer C. D. A., Schalkwijk C. G., Tanaka S., Matsuzawa Y., Kobes S., Tataranni P. A., Hanson R. L., Knowler W. C., Lindsay R. S., Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 2003 26 6 1745 1751 2-s2.0-10744231067 10.2337/diacare.26.6.1745
144. Lindsay R. S., Funahashi T., Hanson R. L., Matsuzawa Y., Tanaka S., Tataranni P. A., Knowler W. C., Krakoff J., Adiponectin and development of type 2 diabetes in the Pima Indian population. The Lancet 2002 360 9326 57 58 2-s2.0-0037031088 10.1016/S0140-6736(02)09335-2
145. Lau D. C. W., Dhillon B., Yan H., Szmitko P. E., Verma S., Adipokines: molecular links between obesity and atheroslcerosis. American Journal of Physiology: Heart and Circulatory Physiology 2005 288 5 H2031 H2041 2-s2.0-18044366410 10.1152/ajpheart.01058.2004
146. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Hanafusa T., Matsuzawa Y., Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 6 1595 1599 2-s2.0-0034096988
147. Hanley A. J., Wagenknecht L. E., Norris J. M., Adiponectin and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family study. Diabetes Care 2011 34 10 2231 2236 10.2337/dc11-0531
148. Hotta K., Funahashi T., Bodkin N. L., Ortmeyer H. K., Arita Y., Hansen B. C., Matsuzawa Y., Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001 50 5 1126 1133 2-s2.0-0035039227
149. Tu J. V., Reducing the global burden of stroke: INTERSTROKE. The Lancet 2010 376 9735 74 75 2-s2.0-77955013329 10.1016/S0140-6736(10)60975-0
150. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., Abbott R., Godwin J., Dyer A., Stamler J., Blood pressure, stroke, and coronary heart disease-part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. The Lancet 1990 335 8692 765 774 2-s2.0-0025234906 10.1016/0140-6736(90)90878-9
151. O'Rourke M. F., Safar M. E., Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005 46 1 200 204 2-s2.0-21744459081 10.1161/01.HYP.0000168052. 00426.65
152. Qiu C., Winblad B., Fratiglioni L., The age-dependent relation of blood pressure to cognitive function and dementia. The Lancet Neurology 2005 4 8 487 499 2-s2.0-22144451172 10.1016/S1474-4422(05)70141-1
153. Staessen J. A., Richart T., Birkenhäger W. H., Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension 2007 49 3 389 400 2-s2.0-33847080863 10.1161/01.HYP.0000258151. 00728.d8
154. Nagai M., Hoshide S., Kario K., Hypertension and dementia. American Journal of Hypertension 2010 23 2 116 124 2-s2.0-75649100919 10.1038/ajh.2009.212
155. Launer L. J., Ross G. W., Petrovitch H., Masaki K., Foley D., White L. R., Havlik R. J., Midlife blood pressure and dementia: the Honolulu-Asia Aging study. Neurobiology of Aging 2000 21 1 49 55 2-s2.0-0034594441 10.1016/S0197-4580(00)00096-8
156. Launer L. J., Masaki K., Petrovitch H., Foley D., Havlik R. J., The association between midlife blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging study. The Journal of the American Medical Association 1995 274 23 1846 1851 2-s2.0-0029617996 10.1001/jama.274.23.1846
157. Jellinger K. A., Attems J., Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathologica 2010 119 4 421 433 2-s2.0-77953024802 10.1007/s00401-010-0654-5
158. Nelson P. T., Head E., Schmitt F. A., Davis P. R., Neltner J. H., Jicha G. A., Abner E. L., Smith C. D., van Eldik L. J., Kryscio R. J., Scheff S. W., Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. Acta Neuropathologica 2011 121 5 571 587 2-s2.0-79958116172 10.1007/s00401-011-0826-y
159. Waldstein S. R., Rice S. C., Thayer J. F., Najjar S. S., Scuteri A., Zonderman A. B., Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension 2008 51 1 99 104 2-s2.0-37349083147 10.1161/HYPERTENSIONAHA.107.093674
160. Qiu C., Winblad B., Viitanen M., Fratiglioni L., Pulse pressure and risk of alzheimer disease in persons aged 75 years and older: a community-based, longitudinal study. Stroke 2003 34 3 594 599 2-s2.0-0037337343 10.1161/01.STR.0000060127.96986.F4
161. Lee A. Y., Jeong S.-H., Choi B. H., Sohn E. H., Chui H., Pulse pressure correlates with leukoaraiosis in Alzheimer disease. Archives of Gerontology and Geriatrics 2006 42 2 157 166 2-s2.0-29144458950 10.1016/j.archger.2005.06.009
162. Nation D. A., Wierenga C. E., Delano-Wood L., Jak A. J., Delis D. C., Salmon D. P., Bondi M. W., Elevated pulse pressure is associated with age-related decline in language ability. Journal of the International Neuropsychological Society 2010 16 5 933 938 2-s2.0-79451471582 10.1017/S1355617710000548
163. Skoog I., Lernfelt B., Landahl S., Palmertz B., Andreasson L.-A., Nilsson L., Persson G., Odén A., Svanborg A., 15-year longitudinal study of blood pressure and dementia. The Lancet 1996 347 9009 1141 1145 2-s2.0-0030603535
164. Molander L., Gustafson Y., Lövheim H., Longitudinal associations between blood pressure and dementia in the very old. Dementia and Geriatric Cognitive Disorders 2010 30 3 269 276 2-s2.0-77956601733 10.1159/000320252
165. Huang P. L., Huang Z., Mashimo H., Bloch K. D., Moskowitz M. A., Bevan J. A., Fishman M. C., Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995 377 6546 239 242 2-s2.0-0029021148
166. Guzik T. J., Black E., West N. E., Relationship between the G894T polymorphism (Glu 298 Asp variant) in endothelial nitric oxide synthase and nitric oxide-mediated endothelial function in human atherosclerosis. American Journal of Medical Genetics 2001 100 2 130 137 2-s2.0-0035932773 10.1002/ajmg.1229
167. Zhu W., Cheng K. K. Y., Vanhoutte P. M., Lam K. S. L., Xu A., Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clinical Science 2008 114 5-6 361 374 2-s2.0-39549094717 10.1042/CS20070347
168. Ouedraogo R., Gong Y., Berzins B., Wu X., Mahadev K., Hough K., Chan L., Goldstein B. J., Scalia R., Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. The Journal of Clinical Investigation 2007 117 6 1718 1726 2-s2.0-34249900491 10.1172/JCI29623
169. Shibata R., Ouchi N., Kihara S., Sato K., Funahashi T., Walsh K., Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of AMP-activated protein kinase signaling. The Journal of Biological Chemistry 2004 279 27 28670 28674 2-s2.0-3142616447 10.1074/jbc.M402558200
170. Chen H., Montagnani M., Funahashi T., Shimomura I., Quon M. J., Adiponectin stimulates production of nitric oxide in vascular endothelial cells. The Journal of Biological Chemistry 2003 278 45 45021 45026 2-s2.0-0242581695 10.1074/jbc.M307878200
171. Ouchi N., Kobayashi H., Kihara S., Kumada M., Sato K., Inoue T., Funahashi T., Walsh K., Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. The Journal of Biological Chemistry 2004 279 2 1304 1309 2-s2.0-0346463030 10.1074/jbc.M310389200
172. Kobayashi H., Ouchi N., Kihara S., Walsh K., Kumada M., Abe Y., Funahashi T., Matsuzawa Y., Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circulation Research 2004 94 4 e27 e31 2-s2.0-2942720979
173. Takahashi A., Kureishi Y., Yang J., Luo Z., Guo K., Mukhopadhyay D., Ivashchenko Y., Branellec D., Walsh K., Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. Molecular and Cellular Biology 2002 22 13 4803 4814 2-s2.0-0036269886 10.1128/MCB.22.13.4803-4814.2002
174. Mahadev K., Wu X., Donnelly S., Ouedraogo R., Eckhart A. D., Goldstein B. J., Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells. Cardiovascular Research 2008 78 2 376 384 2-s2.0-42149117692 10.1093/cvr/cvn034
175. Goldstein B. J., Scalia R. G., Ma X. L., Protective vascular and myocardial effects of adiponectin. Nature Clinical Practice: Cardiovascular Medicine 2009 6 1 27 35 10.1038/ncpcardio1398
176. Takaoka M., Nagata D., Kihara S., Shimomura I., Kimura Y., Tabata Y., Saito Y., Nagai R., Sata M., Periadventitial adipose tissue plays a critical role in vascular remodeling. Circulation Research 2009 105 9 906 911 2-s2.0-70350721917 10.1161/CIRCRESAHA.109.199653
177. Goldstein B. J., Scalia R., Adiponectin: a novel adipokine linking adipocytes and vascular function. The Journal of Clinical Endocrinology & Metabolism 2004 89 6 2563 2568 2-s2.0-2942687834 10.1210/jc.2004-0518
178. Beach T. G., Wilson J. R., Sue L. I., Newell A., Poston M., Cisneros R., Pandya Y., Esh C., Connor D. J., Sabbagh M., Walker D. G., Roher A. E., Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathologica 2007 113 1 13 21 2-s2.0-33751219894 10.1007/s00401-006-0136-y
179. Stary H. C., Natural history and histological classification of atherosclerotic lesions an update. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 5 1177 1178 2-s2.0-0034020018
180. Stary H. C., Chandler A. B., Dinsmore R. E., Fuster V., Glagov S., Insull W. Jr., Rosenfeld M. E., Schwartz C. J., Wagner W. D., Wissler R. W., A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995 92 5 1355 1374 2-s2.0-0029097154
181. Korf E. S. C., White L. R., Scheltens P., Launer L. J., Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging study. Hypertension 2004 44 1 29 34 2-s2.0-3042538272 10.1161/01.HYP.0000132475.32317. bb
182. Deguchi J.-O., Aikawa E., Libby P., Vachon J. R., Inada M., Krane S. M., Whittaker P., Aikawa M., Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation 2005 112 17 2708 2715 2-s2.0-27444439210 10.1161/CIRCULATIONAHA.105.562041
183. Deguchi J.-O., Aikawa M., Tung C.-H., Aikawa E., Kim D.-E., Ntziachristos V., Weissleder R., Libby P., Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 2006 114 1 55 62 2-s2.0-33746223025 10.1161/CIRCULATIONAHA.106.619056
184. Dollery C. M., Owen C. A., Sukhova G. K., Krettek A., Shapiro S. D., Libby P., Neutrophil elastase in human atherosclerotic plaques production by macrophages. Circulation 2003 107 22 2829 2836 2-s2.0-0037782348 10.1161/01.CIR.0000072792.65250.4A
185. Larionov S., Dedeck O., Birkenmeier G., Thal D. R., Expression of α 2-macroglobulin, neutrophil elastase, and interleukin-1 α differs in early-stage and late-stage atherosclerotic lesions in the arteries of the circle of Willis. Acta Neuropathologica 2007 113 1 33 43 2-s2.0-33751226922 10.1007/s00401-006-0134-0
186. Liang J., Liu E., Yu Y., Kitajima S., Koike T., Jin Y., Morimoto M., Hatakeyama K., Asada Y., Watanabe T., Sasaguri Y., Watanabe S., Fan J., Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits. Circulation 2006 113 16 1993 2001 2-s2.0-33646179200 10.1161/CIRCULATIONAHA.105.596031
187. Han S. H., Quon M. J., Kim J.-A., Koh K. K., Adiponectin and cardiovascular disease: response to therapeutic interventions. Journal of the American College of Cardiology 2007 49 5 531 538 2-s2.0-33846618661 10.1016/j.jacc.2006.08.061
188. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., Hotta K., Nishida M., Takahashi M., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y., Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF- B signaling through a cAMP-dependent pathway. Circulation 2000 102 11 1296 1301 2-s2.0-0034641647
189. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y., Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999 100 25 2473 2476 2-s2.0-0033613545
190. Ouchi N., Kihara S., Arita Y., Nishida M., Matsuyama A., Okamoto Y., Ishigami M., Kuriyama H., Kishida K., Nishizawa H., Hotta K., Muraguchi M., Ohmoto Y., Yamashita S., Funahashi T., Matsuzawa Y., Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001 103 8 1057 1063 2-s2.0-0035957040
191. Allan L. M., Rowan E. N., Firbank M. J., Thomas A. J., Parry S. W., Polvikoski T. M., O'Brien J. T., Kalaria R. N., Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain 2011 134 12 3716 3727 2-s2.0-84857076677
192. Leys D., Hénon H., Mackowiak-Cordoliani M.-A., Pasquier F., Poststroke dementia. The Lancet Neurology 2005 4 11 752 759 2-s2.0-26844575657 10.1016/S1474-4422(05)70221-0
193. Pendlebury S. T., Rothwell P. M., Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. The Lancet Neurology 2009 8 11 1006 1018 2-s2.0-70449132694 10.1016/S1474-4422(09)70236-4
194. Reitz C., Bos M. J., Hofman A., Koudstaal P. J., Breteler M. M. B., Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam study. Stroke 2008 39 1 36 41 2-s2.0-38149116434 10.1161/STROKEAHA. 107.490334
195. Schaapsmeerders P., Maaijwee N. A., van Dijk E. J., Long-term cognitive impairment after first-ever ischemic stroke in young adults. Stroke 2013 44 6 1621 1628 10.1161/STROKEAHA.111.000792
196. Kokmen E., Whisnant J. P., O'Fallon W. M., Chu C.-P., Beard C. M., Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology 1996 46 1 154 159 2-s2.0-0029933840
197. Grant I., Rochford J., Fleming T., Stunkard A., A neuropsychological assessment of the effects of moderate marihuana use. Journal of Nervous and Mental Disease 1973 156 4 278 280 2-s2.0-0015605703
198. Stott D. J., Welsh P., Rumley A., Robertson M., Ford I., Sattar N., Westendorp R. G. J., Jukema J. W., Cobbe S. M., Lowe G. D. O., Adipocytokines and risk of stroke in older people: a nested case-control study. International Journal of Epidemiology 2009 38 1 253 261 2-s2.0-60149084187 10.1093/ije/dyn215
199. Prugger C., Luc G., Haas B., Arveiler D., MacHez E., Ferrieres J., Ruidavets J.-B., Bingham A., Montaye M., Amouyel P., Yarnell J., Kee F., Ducimetiere P., Empana J.-P., Adipocytokines and the risk of ischemic stroke: the PRIME study. Annals of Neurology 2012 71 4 478 486 2-s2.0-84860197535 10.1002/ana.22669
200. Savopoulos C., Michalakis K., Apostolopoulou M., Miras A., Hatzitolios A., Adipokines and stroke: a review of the literature. Maturitas 2011 70 4 322 327 2-s2.0-80755153587 10.1016/j.maturitas.2011.09.002
201. Kim B. J., Lee S.-H., Ryu W.-S., Kim C. K., Yoon B.-W., Adipocytokines and ischemic stroke: differential associations between stroke subtypes. Journal of the Neurological Sciences 2012 312 1-2 117 122 2-s2.0-84155164672 10.1016/j.jns.2011.08.007
202. Nakamura Y., Shimada K., Fukuda D., Shimada Y., Ehara S., Hirose M., Kataoka T., Kamimori K., Shimodozono S., Kobayashi Y., Yoshiyama M., Takeuchi K., Yoshikawa J., Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 2004 90 5 528 533 2-s2.0-11144354080
203. Otsuka F., Sugiyama S., Kojima S., Maruyoshi H., Funahashi T., Matsui K., Sakamoto T., Yoshimura M., Kimura K., Umemura S., Ogawa H., Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. Journal of the American College of Cardiology 2006 48 6 1155 1162 2-s2.0-33748415363 10.1016/j.jacc.2006.05.054
204. Kumada M., Kihara S., Sumitsuji S., Association of hypoadiponectinemia with coronary artery disease in men. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 1 85 89 10.1161/01.ATV.0000048856.22331.50
205. Shibata R., Sato K., Pimentel D. R., Takemura Y., Kihara S., Ohashi K., Funahashi T., Ouchi N., Walsh K., Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nature Medicine 2005 11 10 1096 1103 2-s2.0-27144457438 10.1038/nm1295
206. Tao L., Jiao X., Gao E., Lau W. B., Yuan Y., Lopez B., Christopher T., Ramachandrarao S. P., Williams W., Southan G., Sharma K., Koch W., Ma X. L., Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis. Circulation 2006 114 13 1395 1402 2-s2.0-33749035991 10.1161/CIRCULATIONAHA.106.625061
207. Shibata R., Ouchi N., Ito M., Kihara S., Shiojima I., Pimentel D. R., Kumada M., Sato K., Schiekofer S., Ohashi K., Funahashi T., Colucci W. S., Walsh K., Adiponectin-mediated modulation of hypertrophic signals in the heart. Nature Medicine 2004 10 12 1384 1389 2-s2.0-19944369735 10.1038/nm1137
208. Jung Y. S., Ha S. K., Kim S. D., Kim S. H., Lim D. J., Choi J. I., The role of adiponectin in secondary inflammatory reaction in cerebral ischemia. Journal of Cerebrovascular and Endovascular Neurosurgery 2013 15 3 171 176 10.7461/jcen.2013.15.3.171
209. Nishimura M., Izumiya Y., Higuchi A., Shibata R., Qiu J., Kudo C., Shin H. K., Moskowitz M. A., Ouchi N., Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase-dependent mechanisms. Circulation 2008 117 2 216 223 2-s2.0-38049178556 10.1161/CIRCULATIONAHA.107.725044
210. Song W., Huo T., Guo F., Globular adiponectin elicits neuroprotection by inhibiting NADPH oxidase-mediated oxidative damage in ischemic stroke. Neuroscience 2013 248 136 144 10.1016/j.neuroscience.2013.05.063
211. Shen L., Miao J., Yuan F., Zhao Y., Tang Y., Wang Y., Zhao Y., Yang G.-Y., Overexpression of adiponectin promotes focal angiogenesis in the mouse brain following middle cerebral artery occlusion. Gene Therapy 2013 20 1 93 101 2-s2.0-84857207928 10.1038/gt.2012.7
212. Nagata D., Mogi M., Walsh K., AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. The Journal of Biological Chemistry 2003 278 33 31000 31006 2-s2.0-0042733154 10.1074/jbc.M300643200
213. Ouchi N., Shibata R., Walsh K., AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle. Circulation Research 2005 96 8 838 846 2-s2.0-18044393806 10.1161/01.RES.0000163633.10240.3b